Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron's Q3 Revenue Climbs 8 Percent Though Profits Slide 15 Percent

NEW YORK (GenomeWeb News) — Thermo Electron today said that third-quarter profit declined 15 percent even as revenues climbed 8 percent.
 
Total receipts for the quarter ended Sept. 30 increased to $725 million from $679 million last year.
 
Thermo Electron said positive revenue growth came from mass spec sales, small molecule research, and increased elemental analysis sales in its Life and Lab Sciences division, which rose 5 percent in the current period to $543 million from $516 million last year.
 
Led by sales on online systems for commodity materials, sales in the company’s Measurement and Control division were up 11 percent to $181 million from $163 million last year.
 
R&D spending in the quarter declined 5.3 percent in the quarter to $38.7 million from $38.8 million year over year.
 
The company said earnings in the quarter declined to $48.8 million from $57.7 million year over year. The company said the decrease in profits “reflect a $.03 impact from stock option expense for rules that became effective this year, and 2005 earnings included a $.10 net gain from the disposal of discontinued businesses.”
 
Thermo had around $158 million in cash, equivalents, and short-term available-for-sale investments as of Sept. 30.
 
Thermo said it expects to post between $2.88 billion and $2.90 billion in revenues this year, which would be between 9 percent and 10 percent stronger than revenues in 2005.
 
Thermo Electron is awaiting clearance from the European Commission to complete its merger with Fisher Scientific. As a condition of the deal, Fisher said it would divest its Genevac business. Both companies said they expect to close the deal by Nov. 9.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.